Osteopore
Developer and manufacturer of 3D-printed bioresorbable implants that facilitate natural bone regeneration.
- CEO / Founder
- Khoon Seng Goh
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $5.25M
- Latest Round
- Post-IPO Equity
- Key Investors
- NTUitive; Institutional, high net worth and sophisticated investors (IPO)
Technology & Products
Key Products
3D printed bioresorbable implants for bone and tissue regeneration, patient-specific surgical models, and sterilized cutting jigs.
Technological Advantage
Microarchitecture design that mimics natural bone structure while meeting specific geometrical needs for reconstruction.
Differentiation
Value Proposition
Bioresorbable implants that dissolve over time while promoting natural bone regeneration, reducing post-surgery complications compared to permanent implants.
How They Differentiate
Unique combination of 3D printing technology with bioresorbable materials that promotes natural bone regeneration.
Market & Competition
Target Customers
Hospitals, surgical centers, and healthcare providers performing neurosurgical, orthopedic, and maxillofacial surgeries
Industry Verticals
["Neurosurgery","Orthopedics","Maxillofacial Surgery","Dental Surgery"]
Competitors
Matrix Meditec Pvt, Bloocell
Growth & Milestones
Growth Metrics
Revenue of approximately $1M in 2018 with continued growth through expanded market presence.
Major Milestones
["Over 30,000 successful surgeries performed","First-in-human 3D printed patient-specific implant for mandibular reconstruction","Expansion into multiple international markets","Successful development of new OrthoMag product line"]
Notable Customers
Major hospitals; Surgical centers; Healthcare providers globally